Novel pyrazolo[1,5-a]pyridines as orally active EP1 receptor antagonists: Synthesis, structure-activity relationship studies, and biological evaluation

Add time:08/02/2019    Source:sciencedirect.com

Novel pyrazolo[1,5-a]pyridine derivatives were designed, synthesized and evaluated as orally active EP1 antagonists for the treatment of overactive bladder. Matched molecular pair analysis (MMPA) allowed the design of a new series of pyrazolo[1,5-a]pyridine derivatives 4–6. Structure-activity relationships (SAR) studies of 4–6 were performed, leading to identification of the nanomolar-level EP1 antagonist 4c, which exhibited good pharmacological effect through intraduodenal (id) administration in a 17-phenyltrinor prostaglandin E2-induced bladder contraction model in rats.

We also recommend Trading Suppliers and Manufacturers of 2-Chloro-3-(chloromethyl)pyridine hydrochloride (cas 106651-82-5). Pls Click Website Link as below: cas 106651-82-5 suppliers

Prev:A novel pyridine based polymer for highly efficient separation of nickel from high-acidity and high-concentration cobalt solutions
Next:Synthesis, structure elucidation, DNA-PK and PI3K and anti-cancer activity of 8- and 6-aryl-substituted-1-3-benzoxazines)